Ablation of androgen production through surgery is one strategy against prostate cancer, with the current focus placed on pharmaceutical intervention to restrict androgen synthesis selectively, an endeavor that could benefit from the enhanced understanding of enzymatic mechanisms that derives from characterization of key reaction intermediates.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The multifunctional cytochrome P450 17A1 (CYP17A1) first catalyzes the typical hydroxylation of its primary substrate, pregnenolone (PREG) and then also orchestrates a remarkable C17-C20 bond cleavage (lyase) reaction, converting the 17-hydroxypregnenolone initial product to dehydroepiandrosterone, a process representing the first committed step in the biosynthesis of androgens. Now, we report the capture and structural characterization of intermediates produced during this lyase step: an initial peroxo-anion intermediate, poised for nucleophilic attack on the C20 position by a substrate-associated H-bond, and the crucial ferric peroxo-hemiacetal intermediate that precedes carbon-carbon (C-C) bond cleavage. These studies provide a rare glimpse at the actual structural determinants of a chemical transformation that carries profound physiological consequences.
Proceedings of the National Academy of Sciences of the United States of America. 2015 Dec 14 [Epub ahead of print]
Piotr J Mak, Michael C Gregory, Ilia G Denisov, Stephen G Sligar, James R Kincaid
Department of Chemistry, Marquette University, Milwaukee, WI 53233;, Department of Biochemistry, University of Illinois, Urbana, IL 61801;, Department of Biochemistry, University of Illinois, Urbana, IL 61801;, Department of Biochemistry, University of Illinois, Urbana, IL 61801; Department of Chemistry, University of Illinois, Urbana, IL 61801; College of Medicine, University of Illinois, Urbana, IL 61801. Department of Chemistry, Marquette University, Milwaukee, WI 53233